Skip to main content
Top
Published in: Medical Oncology 9/2015

01-09-2015 | Letter to the Editor

Role of decreased immunosupression regimen in a heart transplant recipient with more than 500 squamous cell cancers

Authors: Mansher Singh, Christopher Lim, Elof Eriksson

Published in: Medical Oncology | Issue 9/2015

Login to get access

Excerpt

Dear Sir, …
Literature
1.
go back to reference Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumors posttransplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29:828–30.CrossRefPubMed Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumors posttransplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29:828–30.CrossRefPubMed
2.
go back to reference Liu AS, Eriksson E. Four hundred seventeen squamous cell cancers in a heart transplant patient. Ann Plast Surg. 2011;67(5):545–6.CrossRefPubMed Liu AS, Eriksson E. Four hundred seventeen squamous cell cancers in a heart transplant patient. Ann Plast Surg. 2011;67(5):545–6.CrossRefPubMed
3.
go back to reference Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP. Effect of long-term immunosuppressive in kidney-graft recipients on cancer incidence: randomized comparison of two cyclosporine regimens. Lancet. 1998;351:623–8.CrossRefPubMed Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP. Effect of long-term immunosuppressive in kidney-graft recipients on cancer incidence: randomized comparison of two cyclosporine regimens. Lancet. 1998;351:623–8.CrossRefPubMed
Metadata
Title
Role of decreased immunosupression regimen in a heart transplant recipient with more than 500 squamous cell cancers
Authors
Mansher Singh
Christopher Lim
Elof Eriksson
Publication date
01-09-2015
Publisher
Springer US
Published in
Medical Oncology / Issue 9/2015
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-015-0674-z

Other articles of this Issue 9/2015

Medical Oncology 9/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine